<!-- Content: Immunotherapy -->
<div class="content-container">
  <section id="intro" class="section">
    <h2 class="section-title gradient-text">Immunotherapy for Sarcoma & LMS</h2>
    <p class="muted">Below are curated links and the verbatim block you provided, placed directly on the page (no archive) for easy reading.</p>
  </section>

  <section id="lms-updates" class="section">
    <h2 class="section-title gradient-text">LMS Immunotherapy Updates / Clinical Trials</h2>
    <div class="card">
      <!-- BEGIN: user-provided HTML inserted verbatim -->
      <div class="elementor-widget-wrap">
        <div class="elementor-element elementor-element-451754f elementor-widget elementor-widget-text-editor" data-id="451754f" data-element_type="widget" data-widget_type="text-editor.default">
          <div class="elementor-widget-container">
            <div class="elementor-text-editor elementor-clearfix">
              <div><div><strong><span style="color: #339966;">LMS IMMUNOTHERAPY UPDATES/CLINICAL TRIALS</span></strong></div><div><div>&nbsp;</div></div></div><h4><strong><a href="https://cancerresearch.org/immunotherapy/cancer-types/sarcoma">How is Immunotherapy Changing the Outlook for Patients with Sarcoma?</a></strong></h4><div><p class="solo_record">&nbsp;</p><div class="row"><div class="column left"><div class="usa-alert usa-alert-warning"><p class="solo_record"><strong><a href="https://clinicaltrials.gov/ct2/show/study/NCT03074318#contacts">Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery</a></strong></p><div class="row"><div class="column left"><div class="usa-alert usa-alert-warning"><p><strong><a href="https://www.ncbi.nlm.nih.gov/pubmed/29308311">Increased infiltration of M2-macrophages, T-cells and PD-L1 expression in high-grade leiomyosarcomas supports immunotherapeutic strategies</a></strong></p></div></div></div></div></div></div><p><img decoding="async" src="https://ci5.googleusercontent.com/proxy/ywU5zxvkec_UzQJcJxfYXjUVUo5H0ajcIOY9Zfchaqhcr49UowGiIhoC1oKo-OHmscrlr-YZmggPynqhL750PHQZnh3tCac4bNNY3KE2r7ZPAFhNy07h4TRgjmg5eKCVl6vc-j6sjpf7iec=s0-d-e1-ft#https://tse2.mm.bing.net/th?id=OVP._NzI7ewJQeiLOQjJ1GY8pwEsCo&pid=Api&w=250&h=143&c=7" alt="An Early-Stage Trial of Immunotherapy for Advanced Sarcomas"></p><p class="title style-scope ytd-video-primary-info-renderer"><strong><a href="https://www.youtube.com/watch?v=yyZffpH0SQE">An Early-Stage Trial of Immunotherapy for Advanced Sarcomas</a></strong>video&nbsp;by Dr. Arun Singh, 2015</p><div class="m_-2119815498340528025aolmail_contentItem"><div class="m_-2119815498340528025aolmail_contentTitle"><strong><a class="m_-2119815498340528025aolmail_algoLink" href="https://www.cancerresearch.org/we-are-cri/home/cancer-types/sarcoma" target="_blank" rel="noopener noreferrer">CRI – Sarcoma&nbsp;Immunotherapy&nbsp;– Cancer Research Institute</a></strong></div></div><p><strong><a href="https://www.news-medical.net/news/20170503/Study-suggests-how-existing-and-emerging-immunotherapy-treatments-could-be-successful-for-sarcomas.aspx">Current and ongoing immunotherapy treatments hold promise &nbsp;for sarcomas – in particular, these studies are looking at Leiomyosarcomas and pleomorphic sarcoma</a></strong></p><div><div>&nbsp;<img decoding="async" class="CToWUd" src="https://ci6.googleusercontent.com/proxy/z52WmP7hITN8Xv_8EtD9dH9YzsGLHetTa5E9JJjl2Kpqq-WoXLxfiCfJn0nPLK0SImWIg3e1QqTf7_9l8o4qTe39QIi8Xew6TxWedz6fHO2LSBIKtpFGjL2FwydzBeQ=s0-d-e1-ft#https://a.doctor.com/img?p=providers/201667-Bartosz_Chmielowski.jpg&w=141" alt="Dr. Bartosz B Chmielowski, MD, PHD"></div><div><p class="m_6337906505439317291hac"><strong><a href="https://www.youtube.com/watch?v=s_1hlQNOXEQ">Leiomyosarcoma: Immunotherapy Clinical Trials</a></strong>&nbsp; video by Dr. Bartosz Chmielowski, 2017</p><p><img decoding="async" class="CToWUd" src="https://ci4.googleusercontent.com/proxy/MwvHmU5C_aEkkLPFgLSuu6anfZHu_4A7AiF0zG_mwUhl8KMiJlYIqKxsZXhc3n_gsgKcd05nQMtxE6ddzsyT-GD2Q-VN3V4FUlcyEEMKYFyxSw5f9cjwU0-iRA=s0-d-e1-ft#http://phydatabase.med.miami.edu/Documents/Pictures/Breelyn_Wilky.jpg" alt="Breelyn A. Wilky, M.D."></p></div></div><div><p><strong><a class="m_-2119815498340528025find" href="https://www.youtube.com/watch?v=PR-sqscSt1I" target="_blank" rel="f:url noopener">Dr. Wilky on Immunotherapy Trial in Sarcoma </a></strong>by Dr. Wilky, 2017</p></div><div class="m_-2119815498340528025aolmail_contentItem"><div><div><p class="title style-scope ytd-video-primary-info-renderer"><a href="https://www.youtube.com/watch?v=Zv-Zjf09haA"><strong>Efficacy With PD-1 Inhibitor in Uterine Leiomyosarcoma</strong></a>&nbsp; video by Dr. Suzanne George, 2017</p></div></div><div><div class="m_-2119815498340528025aolmail_aolmail_aolmail_site-card-content"><div class="m_-2119815498340528025aolmail_contentItem"><p><strong><a href="http://www.onclive.com/web-exclusives/exceptional-responder-to-pembrolizumab-guides-immunotherapy-progress-in-leiomyosarcoma">Exceptional Responder to Pembrolizumab Guides Immunotherapy Progress in Leiomyosarcoma</a></strong></p></div><div class="m_-2119815498340528025aolmail_contentItem"><div class="title"><p><strong><a href="https://www.fredhutch.org/en/news/releases/2017/immune-profiling-sarcomas-shows-susceptibility-immunotherapy.html">First extensive immune profiling of sarcomas shows some likely susceptible to immunotherapy</a></strong></p></div></div></div></div><div><div><p><strong><a href="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy">Immunotherapy to Treat Cancer</a></strong></p></div></div></div></div><p><strong><a href="http://www.discovercarebelieve.org/app/uploads/2015/01/5688-PD-L1-and-Immunotherapy-White-Paper.pdf">PD-L1 and Immunotherapy – An overview</a></strong></p><div><h3><span style="color: #99cc00;"><strong>Web presentations on Immunotherapy for Sarcoma / Leiomyosarcoma:</strong></span></h3></div><p><a class="m_6337906505439317291find" href="https://www.fredhutch.org/en/news/releases/2017/06/immune-responses-from-early-study-of-novel-sarcoma-vaccine.html" target="_blank" rel="f:url noopener"><strong>Immune responses from early study of novel sarcoma vaccine</strong></a></p><p class="content-title__title"><strong><a href="https://www.ncbi.nlm.nih.gov/pubmed/28440953">Immunotherapy with single-agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study</a></strong></p><div><div class="MainTitleSection"><p class="ArticleTitle" lang="en"><strong><a href="https://clinicalsarcomaresearch.biomedcentral.com/articles/10.1186/s13569-017-0077-3">Overexpressed PRAME is a potential immunotherapy target in sarcoma subtypes</a></strong></p></div></div><h2 class="m_6337906505439317291hac"><strong><a href="https://www.cancerresearch.org/webinars">Cancer immunotherapy webinars</a></strong></h2><p>The full series of monthly immunotherapy webinars from Cancer Research Institute.</p><div><h3><span style="color: #99cc00;"><strong>Below is a video explanation of Checkpoint Inhibitors which is currently being explored for LMS.</strong></span></h3></div><p><span class="embed-youtube" style="text-align:center; display: block;"><iframe class="youtube-player" width="720" height="405" src="https://www.youtube.com/embed/v9NBUeU3PG0?version=3&rel=1&showsearch=0&showinfo=1&iv_load_policy=1&fs=1&hl=en-US&autohide=2&wmode=transparent" allowfullscreen="true" style="border:0;" sandbox="allow-scripts allow-same-origin allow-popups allow-presentation"></iframe></span></p>
              <!-- END: user-provided HTML -->
            </div>
          </div>
        </div>
      </div>
    </div>
  </section>

  <section id="videos" class="section">
    <h2 class="section-title gradient-text">Expert Videos</h2>
    <p class="muted">Key presentations referenced above from Drs. Singh, Chmielowski, Wilky, and George.</p>
  </section>

  <section id="foundations" class="section">
    <h2 class="section-title gradient-text">Foundational Resources</h2>
    <ul>
      <li><a href="https://www.cancer.gov/about-cancer/treatment/types/immunotherapy" target="_blank" rel="noopener">NCI: Immunotherapy to Treat Cancer</a></li>
      <li><a href="https://cancerresearch.org/immunotherapy/cancer-types/sarcoma" target="_blank" rel="noopener">CRI: Immunotherapy for Sarcoma</a></li>
    </ul>
  </section>

  <section id="checkpoint" class="section">
    <h2 class="section-title gradient-text">Checkpoint Inhibitors</h2>
    <p class="muted">Background video and context provided in the section above.</p>
  </section>
</div>
